Transaction #15232 · Form 4 · 0001375088-25-000004
Teladoc Health, Inc. · Exercise / conversion · Common Stock
Teladoc Health, Inc. · Transacted December 1, 2025 · Filed December 3, 2025
What does this filing report?
An SEC Form 4 filing for Teladoc Health, Inc. records an exercise / conversion involving Common Stock on December 1, 2025. The reported quantity was 5,350. The filing date is December 3, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Teladoc Health, Inc.
- Company CIK
- 0001477449
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 5,350
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 86,452
- Ownership description
- Not reported
- SEC acceptance time
- Dec 3, 2025, 9:04 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Vandervoort Adam C ↗
CHIEF LEGAL OFFICER, SECRETARY
CIK 0001375088
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- F2
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- F3
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- F4
- The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- F5
- On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- F6
- Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- F7
- One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.